Celprogen introduces in vivo model for human glioblastoma

[News]

Celprogen Inc. has announced that they have successfully validated an in vivo model system for testing efficacy of cancer drugs and also novel drug candidates for Human Glioblastoma.

More... (http://www.news-medical.net/?id=43061)